Late effects of bone marrow transplantation for thalassemia

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 294-299

  Piga, Antonio ^a,c   Longo, Filomena ^a   Voi, Vincenzo ^a   Facello, Silvia ^a   Miniero, Roberto ^b   Dresow, Bernd ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF HAMBURG   (Germany)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFEROXAMINE MESYLATE; IRON; METHOTREXATE;

ADULT; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTAPHERESIS; DEVICE; DIABETES MELLITUS; DIPHTHERIA; ERYTHROCYTE; FEMALE; GROWTH RETARDATION; HEART DISEASE; HEPATITIS B; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; INFECTION; INFECTION RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; IRON STORAGE; LIVER DISEASE; MAJOR CLINICAL STUDY; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS;

POLIOVIRUS;

EID: 0031826760     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10486.x     Document Type: Conference Paper

References (24)

1. LUCARELLI, G. et al. 1995. Bone marrow transplantation in thalassemia. Sem. Hematol. 32(4): 297-303.
2. APPERLEY, J. F. 1993. Bone marrow transplant for the haemoglobinopathies: Past, present and future. Baillieres Clin. Haematol. 6(1): 299-325.
3. LUCARELLI, G. et al. 1996. Marrow transplantation for patients with thalassemia: Results in class 3 patients. Blood 87(5): 2082-2088.
4. LUCARELLI, G. et al. 1990. Bone marrow transplantation in patients with thalassemia. N. Engl. J. Med. 322: 417-421.
5. LUCARELLI, G. 1997. Bone marrow transplantation for thalassaemia. J. Int. Med. (Suppl.) 740: 49-52.
6. GALIMBERTI, M. et al. 1997. Bone marrow transplantation in thalassemia. The experience of Pesaro. Bone Marrow Transplantation 19: 45-47.
7. OLIVIERI, N. F. et al. 1994. Survival in medically treated patients with homozygous β thalassemia. N. Engl. J. Med. 331 (9): 574-578.
8. PICA, A. et al. 1997. Mortality and morbidity in thalassemia with conventional treatment. Bone Marrow Transplantation 19: 11-13.
9. GABUTTI, V. & A. PICA. 1996. Results of long-term iron-chelating therapy. Acta Haematol. 95: 26-36.
10. LOCASCIULLI, A. et al. 1997. Morbidity and mortality due to liver disease in children undergoing allogenic bone marrow transplantation: a 10-year prospective study. Blood 9: 3799-3805.
11. LOCATELLI, F. et al. 1993. Late effects in children after bone marrow transplantation: a review. Haematologica 78: 319-328.
12. DUELL, T. et al. 1997. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann. Intern. Med. 126(3): 184-192.
13. PIGA, A. et al. 1995. Iron overload after bone marrow transplantation in thalassemia. Blood 86 (10) (Suppl 1): 401a.
14. GAROFALO, F. et al. 1997. Antibody levels and response to vaccinations 4-6 years after BMT in thalassemia. Bone Manow Transplantation 19: 145-146.
15. OLIVIERI, N. F. & G. M. BRITTENHAM. 1997. Iron-chelating therapy and the treatment of thalassemia. Blood 89: 739-776.
16. GABUTTI, V. et al. 1993. Computhal: A computerized clinical record for thalassemia. Ciba-Geigy.
17. BRITTENHAM, G. M. et al. 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med. 331 (9): 567-573.
18. WHITERSPOON, R. P. et al. 1989. Secondary cancers after bone marrow transplantation for leukaemia or aplastic anaemia. N. Engl. J. Med. 321: 784-789.
19. RUSSO, A. & G. SCHILIRO. 1987. Thalassemia major and malignancies. Am. J. Hematol. 24: 11-112.
20. MINIERO, R. & P. SARACCO. 1988. Cancer in thalassemia and other hemoglobinopathies. Am. J. Hematol. 27: 74.
21. SANDERS, J. E. 1991. The impact of marrow transplant preparative regimens on subsequent growth and development. Sem. Hematol. 28: 244-249.
22. COHEN, A. et al. 1995. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Bone Marrow Transplantation 15(3):343 348.
23. DE SIMONE, M. et al. 1995. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplantation 15(2): 227-233.
24. ANGELUCCI, E. et al. 1997. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 90: 994-998.